quantiphi-awarded-two-2022-regional-and-global-aws-partner-awards

Quantiphi Awarded Two 2022 Regional and Global AWS Partner Awards

 

Quantiphi, an artificial intelligence (AI)-first digital engineering company and AWS Premier Tier Services Partner in the Amazon Web Services (AWS) Partner Network (APN), is excited to announce it is a recipient of two 2022 Regional and Global AWS Partner Awards, Machine Learning/Artificial Intelligence (ML/AI) Partner of the Year in North America and Industry Partner of the Year in North America.

Announced during a Partner Awards Gala at AWS re: Invent 2022, the Regional and Global AWS Partner Awards recognize a wide range of AWS Partners whose business models have embraced specialization, innovation, and cooperation over the past year. Regional and Global Partner Awards recognize partners whose business models continue to evolve and thrive on AWS as they work with customers.

Already an AWS Premier-tier Partner with the AWS Machine Learning Competency, Quantiphi developed a serverless and scalable machine learning operations platform NeuralOps (MLOps), for its customers. Powered by Amazon SageMaker, the platform created high-quality data attributes and audience propensities at scale.

Quantiphi also helped one of the United States’ largest supplemental insurance companies streamline their rule-based and document-heavy processes by automating claims adjudication. It simplified the process of submitting insurance claims and tracking them, minimizing iterations in the proof of loss documentation.

“Quantiphi is honored to have earned not one, but two Regional and Global AWS Partner Awards this year – the Machine Learning/Artificial Intelligence (ML/AI) Partner of the Year in North America and Industry Partner of the Year in North America,” said Jim Keller, AWS Channel Global Leader at Quantiphi. These strategic awards demonstrate Quantiphi as a compelling and unique AWS Partner for ML/AI and FinServ categories. They also showcase our experience deploying customer solutions on AWS and helping customers realize transformational opportunities through our deep domain knowledge. ”

For the first time, the Regional and Global AWS Partner Awards included a self-nomination process across several award categories and specialization areas awarded at regional and global levels, where all AWS Partners were invited to participate and submit a nomination.

The AWS Partner Network (APN) is a global program focused on helping companies build successful AWS-based businesses or solutions by providing business, technical, marketing, and go-to-market support. The APN includes independent software vendors (ISVs) and systems integrators (Sis) worldwide, with AWS Partner participation growing significantly during the past 12 months.

“AWS Partners are at the center of unlocking value for global customers across a wide range of industries,” said Ruba Borno, Vice President, Worldwide Channels and Alliances at AWS. “We are honored to launch the inaugural global 2022 AWS Partner Awards and thank all the nominees and winners for accelerating our customers’ cloud transformation journey.”

A panel of AWS experts selected the winners based on strict criteria. Quantiphi received Machine Learning/Artificial Intelligence (AI/ML) Partner of the Year in North America.  This award recognized top AWS Partners with Machine Learning Competency who have demonstrated machine learning expertise. Quantiphi was also awarded Industry Partner of the Year in North America, recognizing AWS Partners with deep domain expertise in a specific industry vertical that solves customer pain points or supports their customers in new offerings. Quantiphi helps global financial services firms derive value from cloud-based architectures, big data analytics, and AI by leveraging AWS products and services.

landis+gyr-to-launch-smart-water-meter-and-showcase-latest-grid-edge-and-ev-charging-solutions-at-enlit-europe

Landis+Gyr to Launch Smart Water Meter and Showcase Latest Grid Edge and EV Charging Solutions at Enlit Europe

 

Showcasing its expanded portfolio in Smart Metering, Grid Edge Intelligence and Smart Infrastructure, Landis+Gyr (SIX: LAND) will exhibit the latest hardware and software solutions for electricity, heat, gas and water metering. In addition, the company introduces stations and tools for energy-efficient EV charging.

The company launches its latest addition of ultrasonic smart water meters, W270 and W370, based on IoT technologies. In line with the Landis+Gyr Green Design principles, the new portfolio is 100% recyclable after its extensive lifetime of more than 15 years. In order to deliver valuable information for smart water networks, the meter provides not only data in terms of volume, but also additional information like water temperatures, statistical values, alarms and events. Equipped with modern IoT communication like NB-IoT, the meter is fully integrated into latest generation communication networks, enabling remote control.

In addition, Landis+Gyr showcases its interactive electric vehicle charging line, INCH Pro and INCH Duo which enable the best user experience and reduce operating costs, dynamically balancing charging power for more energy-efficient charging. Accepting digital signals through the power lines and frequency monitoring make INCH chargers capable of autonomously responding to grid conditions – managing the charging power and impact on the electric grid. Furthermore, the OCEAN software, a scalable and remote EV charge point and energy management software, performs advance load management tasks to support demand response and load flexibility services.

Since the launch of Gridstream® Connect, its secure and scalable IoT platform in 2019, Landis+Gyr has been upgrading its suite of smart meters with new variants for residential, industrial and grid measurement needs. Having launched two variants of the E360 residential meters and the second generation of the E660 industrial meter earlier in 2022, Landis+Gyr will round off the year with the launch of the E860 grid meter and the power quality cloud SaaS solution for grid edge intelligence. With ten times the accuracy and speed of modern meters and an extensible modular architecture, the new generation of IoT-ready smart meters by Landis+Gyr offers advanced grid edge intelligence to support DSOs in maintaining a safe, reliable and efficient grid.

“Managing energy consumption with more efficiency has never been more crucial than today”, said Werner Lieberherr, Chief Executive Officer of Landis+Gyr. “If the current energy crisis and the urgent need for global decarbonization have taught us one thing, it’s that resources are finite and having the insights and tools to shape the way they’re used is key.” Bodo Zeug, Executive Vice President of EMEA at Landis+Gyr added: “Utilities require fast, reliable, and secure data transmission. We’re excited to showcase our abilities to collect, monitor and process data at the grid edge at Enlit Europe, providing solutions to balance load and ensure continued power quality and reliability.”

During the conference, Landis+Gyr leaders and experts will host sessions about the role of the future grid and the EV disruption:

  • Interview with Werner Lieberherr, CEO of Landis+Gyr
    Summit: Interview, November 29, 16:40 – 16:55, Afternoon Session, Connect Studio (Hall 11.1)
  • “How to ensure grid resilience in the new energy era” by Ifigeneia Stefanidou, Head of Grid Edge Product Management at Landis+Gyr
    Grid Edge technologies: Utilities at work, November 30, 11:15 – 11:30, Digitalization Hub 4 (Hall 12.0)
  • “EV disruption for more efficient, safer and cleaner grid” by Rok Kobal, Head of Hardware Sales at Etrel – a Landis+Gyr company
    Decentralization | EV for the Grid, November 30, 15:30 – 15:45, Decentralization Hub 1 (Hall 12.0)

To learn more about Landis+Gyr’s energy management portfolio, join us at Enlit Europe in Frankfurt from November 29th to December 1st in Hall 12.1, Booth D40 or visit www.landisgyr.eu/enlit-europe-2022 for more information.

kx-supports-b2c2-for-trading-analytics,-driving-further-innovation-in-the-digital-assets-space

KX Supports B2C2 for Trading Analytics, Driving Further Innovation In the Digital Assets Space

 

KX, maker of kdb+, the world’s fastest time series database and analytics engine, announces that B2C2, the world’s leading crypto liquidity provider and a digital asset pioneer, has expanded its use of KX’s real-time high-performance analytics software, including the deployment of KX Dashboards, its powerful visualization tool. As more institutional firms enter the world of cryptocurrencies, the increased use of KX will enable B2C2 to offer clients tailored products and services at a level that is more akin to what is found at a tier-one investment bank.

KX – which built its technology in the most demanding data environments of capital markets – provides B2C2 with a robust, high-velocity real-time analytics platform, and powerful dashboards for rich data visualization, business intelligence, and reporting capabilities that adapt seamlessly to the needs of digital markets. With kdb+ at its core, the KX analytics technology stack gives B2C2 the capability to process and analyze enormous amounts of data, both time series and relational, at speed and scale for richer actionable intelligence, and critical split-second decision-making.

The adoption of KX Dashboards, the interactive and robust visualization tool for kdb+, follows a thorough evaluation process from B2C2, which is utilizing it across the firm.

Nicola White, Group CEO B2C2: “We are pleased to be working with KX, which supports B2C2 in delivering real-time data-driven trading insights and decisions to digital assets markets. KX is recognized and respected for its industry-leading technology across the world’s major financial institutions and working with them aligns with our clients’ and counterparties’ capabilities.”

James Corcoran, Chief Growth Officer, KX: “We’re delighted to be further strengthening our long-standing relationship with B2C2 by supporting its continued innovation and growth in the digital assets space. KX technology is proven in enhancing a broad range of mission-critical data and trading systems across front, middle and back-office operations for the majority of the world’s leading tier-one banks, brokerages, and investment firms. Our services have extended to other major participants in the global financial ecosystem, including the crypto markets. Together we can continue to drive innovation across the expanded financial services sector.”

B2C2’s success is built on crypto-native technology, sophisticated systematic market making, and risk management, as well as continuous product innovation. It is a recognized leader in the digital assets sector and provides reliable liquidity across multiple market conditions, enabling a broad range of investors, including larger institutions such as investment banks and hedge funds, to gain access to cryptocurrencies and derivatives products.

Built for the modern data ecosystem, KX technology can ingest, store, manage and analyze, time series data and relational data at enormous speed and scale no matter where it sits across an organization.  Its robust visualization dashboards and extensive integration with 3rd party business intelligence tools enable users to make faster, better informed in-the-moment decisions, delivering rapid ROI and measurable business value. A recent Forrester Consulting Total Economic Impact Study found that customers could achieve 315% return on investment (ROI) and less than 6 months’ payback on implementing KX.

natural-killer-(nk)-cell-therapeutics-market-to-perceive-healthy-cagr-of-40.9%-by-2029,-size,-share,-trends,-demand,-opportunities,-challenges-and-competitive-analysis

Natural Killer (NK) Cell Therapeutics Market to Perceive Healthy CAGR of 40.9% by 2029, Size, Share, Trends, Demand, Opportunities, Challenges and Competitive Analysis

 

Data Bridge Market Research completed a qualitative study titled “Natural Killer (NK) Cell Therapeutics Market” with 100+ market data tables, pie charts, graphs, and figures spread across Pages and an easy to grasp full analysis. By keeping into focus customer requirements, an influential Natural Killer (NK) Cell Therapeutics market analysis report has been generated by chewing over quite a lot of market parameters. These factors consist of but are not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. For market segmentation study conducted in the large scale Natural Killer (NK) Cell Therapeutics report, the market of potential customers is divided into groups or segments based on different characteristics such as application of product, deployment model, end user and geographical region etc.

Global natural killer (NK) cell therapeutics market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyses that global natural killer (NK) cell therapeutics market will grow at a CAGR of 40.9% during the forecast period of 2022 to 2029.

Download Sample Copy of Natural Killer (NK) Cell Therapeutics Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-natural-killer-nk-cell-therapeutics-market

Market Overview:

Natural killer (NK) cells therapeutics report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. Contact us for an analyst brief to understand the analysis and the market scenario; our team will help you create a revenue impact solution to achieve your desired goal. An increase in the usage of natural killer cells for the treatment of infectious diseases is the major driver that propelled the market’s demand in the forecast period.

Global natural killer (NK) cell therapeutics comprises features such as an increasing need for better therapeutics options that will impair the manufacturers’ launching new products into the market, enhancing its increased demand investment in research and development leads to the market growth. Currently, various research studies are taking place, which is expected to create a competitive advantage for manufacturers to develop new and innovative natural killer (NK) cell therapeutics that will provide various other opportunities in the natural killer (NK) cells therapeutics market. However, adverse side effects of therapies and unfavorable & inadequate reimbursement scenarios are expected to restrain the market growth in the forecast period.

Opportunities for Players:

  • Strategic Initiatives by Market Players

Market players adopt various strategic initiatives that involve expansion, acquisition, and collaboration, among others. These initiatives help them increase the company’s product portfolio, leading to market expansion and, hence, enhancing the product demand among customers, ultimately leading the players to earn maximum revenue.

As the demand for effective and affordable natural killer (NK) cell immunotherapy is increasing worldwide, these strategic initiatives are taken by top market players aimed at enhancing business operations and earning more profitability in the market.

Some of the major players operating in the Natural Killer (NK) Cell Therapeutics market are:

  • Merck KGaA,
  • Bristol-Myers Squibb Company,
  • Glycostem,
  • Kiadis Pharma,
  • Cytovia Therapeutics,
  • Nkarta, Inc.,
  • Nektar,
  • ImmunityBio, Inc.,
  • Brink Biologics, Inc.,
  • Biohaven Pharmaceuticals,
  • Fate Therapeutics,
  • EMERcell,
  • Phio Pharmaceuticals,
  • PersonGen BioTherapeutics,
  • Innate Pharma, Inc.,
  • INmuneBIO,
  • Gamida Cell,
  • Acepodia Inc.,
  • Affimed GmbH,
  • Multimmune GmbH,
  • iCell Gene Therapeutics,
  • Takeda Pharmaceutical Company Limited,
  • Regeneron Pharmaceuticals

Get Full Research Report to Understand More @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-natural-killer-nk-cell-therapeutics-market

Recent Developments

  • In January 2022Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors.  Through the acquisition, Takeda will obtain Adaptate’s antibody-based γδ T cell engager platform, including pre-clinical candidate and discovery pipeline programs. Adaptate’s γδ T cell engagers are designed to specifically modulate γδ T cell-mediated immune responses at tumor sites while sparing damage to healthy cells. This acquisition help the company to to focus on R&D.
  • In December 2021Nektar Therapeutics announced phase 1b data for novel T regulatory cell stimulator NKTR-358 (LY3471851) in patients with atopic dermatitis. NKTR-358 is designed to treat autoimmune and inflammatory conditions by correcting the immune system imbalance that results from increased levels of inflammatory T cells and reduced numbers and impaired function of immune regulating Treg cells. This has helped company to focus on R&D for further phases.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Natural Killer (NK) Cell Therapeutics market

Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market

Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Natural Killer (NK) Cell Therapeutics Market

THANKSGIVING WEEK SALE!!!

Get UP TO 35%. OFF ON GLOBAL REPORTS. OFFER VALID TILL 30th NOV 2022

For More, Inquire at https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-natural-killer-nk-cell-therapeutics-market

Market Dynamics: Natural Killer (NK) Cell Therapeutics Market

  • Increase in Patient Population with Chronic Diseases

Chronic diseases generally occur in older adults that can be controlled but not cured, such as heart disease, arthritis, diabetes, stroke, or cancer. Chronic diseases are a worldwide healthcare problem concern. The change in lifestyle and physical inactivity, unhealthy diet, and tobacco use increase the burden of chronic diseases worldwide.

An increasing number of the patient population with the chronic disease led the scientist and researchers to work upon the new innovative therapeutic approach to provide patients with the best curative treatment option, which can be achieved by using natural killer (NK) cell therapy that has the potential to generate a strong immune response and has the anti-tumor capability as well.

  • Rise in Awareness about Immunotherapies

As cancer is a devastating disease and available treatment options may cause the reoccurrence of tumors, the need for the best therapeutic approach is increasing day by day. Immunotherapies have attracted much attention in recent years to treat various malignancies. Among the immunotherapies, CAR –T cell therapies have been studied and were used but have several limitations that led to the development of natural killer (NK) cell therapies. As a drug based on the natural killer (NK) cell therapeutic approach has not been approved yet, it thus needs to raise awareness among the population.

This is why several organizations and market players are launching a campaign to enhance natural killer (NK) cell therapies awareness.

Consider Data Bridge Market Research for this Report which would Help Impact Your Revenues Positively

  • This study offers the latest product news, trends, and updates from the industry’s leading players who have leveraged their market position.
  • It also offers strategic plans and standards to arrive at informed business decisions adopted by the main players, thereby advocating your go to market strategies.
  • In addition, it offers insights into the dynamics of customer behaviour that can help the organization better curate market strategies
  • Usage of exclusive tailor-made tools along with primary research, secondary research and our in-house data model helps us in extracting the exact market numbers
  • Mapping the customer in 3P grid comprising of Purpose, Planning and Positioning, thereby delivering a solution by keeping the prospecting client at the sweet spot
  • The Natural Killer (NK) Cell Therapeutics market research report includes all of the market’s valuable elements, such as sales growth, product pricing & analysis, growth opportunities, and recommendations for addressing market challenges
  • The report covers all the primary mergers & acquisitions, alliances, and collaborations that have generated additional opportunities for market players or in some cases, challenges

To Gain More Insights about this Research, Visit @ https://www.databridgemarketresearch.com/reports/global-natural-killer-nk-cell-therapeutics-market

Key Industry Segmentation: Natural Killer (NK) Cell Therapeutics Market

By Therapeutics

  • NK Cell Therapies
  • NK Cell Directed Antibodies

By Approaches

  • Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
  • Bispecific Antibodies

By Application

By End User

  • Research & Academic Institutes
  • Hospitals
  • Specialty Clinics

By Distribution Channel

  • Hospital Pharmacies
  • Direct Tender

Regional Analysis/Insights: Natural Killer (NK) Cell Therapeutics Market

The countries covered in the natural killer (NK) cell therapeutics market report are U.S., CanadaMexicoGermanyFranceItaly, U.K., SpainNetherlandsRussiaSwitzerlandTurkeyAustriaNorwayHungaryLithuaniaIrelandPolandLuxembourg , Rest of EuropeJapanChinaIndiaSouth KoreaAustraliaSingaporeMalaysiaThailandIndonesiaPhilippinesVietnam, Rest of Asia-Pacific , BrazilArgentinaPeru, Rest of South AmericaSaudi ArabiaSouth Africa, UAE, IsraelKuwaitEgypt, Rest of Middle East & Africa.

Asia-Pacific is expected to dominate due to increase in usage of natural killer (NK) cells for the treatment of cancer and infectious diseases.

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Executive Summary
  4. Premium Insights
  5. Global Natural Killer (NK) Cell Therapeutics Market: Regulations
  6. Market Overview
  7. Global Natural Killer (NK) Cell Therapeutics Market, By Therapeutics
  8. Global Natural Killer (NK) Cell Therapeutics Market, By Approaches
  9. Global Natural Killer (NK) Cell Therapeutics Market, By Application
  10. Global Natural Killer (NK) Cell Therapeutics Market, By End User
  11. Global Natural Killer (NK) Cell Therapeutics Market, By Distribution Channel
  12. Global Natural Killer (NK) Cell Therapeutics Market, By Region
  13. Global Natural Killer (NK) Cell Therapeutics Market: Company Landscape
  14. SWOT Analyses
  15. Company Profile
  16. Questionnaires
  17. Related Reports

To Check the Complete Table of contents, click here @ https://www.databridgemarketresearch.com/toc/?dbmr=global-natural-killer-nk-cell-therapeutics-market

Explore More Reports:

Europe Natural Killer (NK) Cell Therapeutics Market, By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application (Cancer, Immunoproliferative Disorders, Acute Infectious Diseases, Gastrointestinal Diseases, Others), End User (Research & Academic Institutes, Hospitals, Specialty Clinics), Distribution Channel (Hospital Pharmacies, Direct Tender, Others) https://www.databridgemarketresearch.com/reports/europe-natural-killer-nk-cell-therapeutics-market

North America Natural Killer (NK) Cell Therapeutics Market, By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application (Cancer, Immunoproliferative Disorders, Acute Infectious Diseases, Gastrointestinal Diseases, Others), End User (Research & Academic Institutes, Hospitals, Specialty Clinics), Distribution Channel (Hospital Pharmacies, Direct Tender, Others) https://www.databridgemarketresearch.com/reports/north-america-natural-killer-nk-cell-therapeutics-market

Asia-Pacific Natural Killer (NK) Cell Therapeutics Market, By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application (Cancer, Immunoproliferative Disorders, Acute Infectious Diseases, Gastrointestinal Diseases, Others), End User (Research & Academic Institutes, Hospitals, Specialty Clinics), Distribution Channel (Hospital Pharmacies, Direct Tender, Others) https://www.databridgemarketresearch.com/reports/asia-pacific-natural-killer-nk-cell-therapeutics-market

Middle East and Africa Natural Killer (NK) Cell Therapeutics Market, By Therapeutics (NK Cell Therapies, NK Cell Directed Antibodies), Approaches (Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), Bispecific Antibodies), Application (Cancer, Immunoproliferative Disorders, Acute Infectious Diseases, Gastrointestinal Diseases, Others), End User (Research & Academic Institutes, Hospitals, Specialty Clinics), Distribution Channel (Hospital Pharmacies, Direct Tender, Others) https://www.databridgemarketresearch.com/reports/middle-east-and-africa-natural-killer-nk-cell-therapeutics-market

Health Tourism Market, By Service (Transport, Accommodation, Hospitality and Others), Type of Treatment (Cosmetic Treatment, Dental Treatment, Cardiovascular Treatment, Orthopaedic Treatment, Bariatric Treatment, Fertility Treatment, Cancer Treatment, Ophthalmic Treatment, Neurological Treatment and Others), Age Group (Senior Citizens, Minors and Adults), By Service Provider (Private and Public) https://www.databridgemarketresearch.com/reports/global-health-tourism-market

Nanomedicine Market, By Product Type (Nano Molecules, Nanoparticles, Liposomes, Polymer And Polymer Drug Conjugates, Hydrogel Nanoparticles, Dendrimers, Nanoshells, Nanotubes And Nanodevices), Application (Vaccines, Regenerative Medicines, Diagnostic Imaging, Drug Delivery, Implants, In-Vitro Imaging, In-Vitro Diagnostics, Therapeutics And Others), Indication (Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopedic Disorders, Neurological Disorders, Urological Disorders, Ophthalmological Diseases, Immunological Diseases, Anti-Inflammatory Diseases, Anti-Infective Diseases And Others) Modality (Treatments And Diagnostics), And Country https://www.databridgemarketresearch.com/reports/global-nanomedicine-market

eHealth Market, By Offering (Solutions and Services), Deployment (Cloud and On-Premises), Enterprise Size (Large Enterprises and Small and Medium Enterprises), Functionality (Content Management System, Group Messaging, Dashboard, Video Sessions, Social Support, and Others), Technology (Internet of Things (IoT), Chatbots, Artificial Intelligence, Block Chain and Big Data, and Others), End User (Healthcare Providers, Payers, Healthcare Consumers, Pharmacies, and Others) https://www.databridgemarketresearch.com/reports/global-ehealth-market

Healthcare Information Technology (IT) Market, By Product and Services (Healthcare Provider Solutions, Healthcare Payer Solutions, Healthcare Information Technology Outsourcing Services), Components (Services, Software, Hardware), Delivery Mode (On-Premise, Cloud-Based), End-Users (Providers, Payers) https://www.databridgemarketresearch.com/reports/global-healthcare-it-market

Diabetes Care Devices Market, By Product (Blood Glucose Monitoring Device, Insulin Delivery Devices), End User (Point of Care, Home Diagnostics, Research Labs, Hospital and Clinics), Country https://www.databridgemarketresearch.com/reports/global-diabetes-care-devices-market

yidu-tech-announces-results-for-the-first-half-of-fy2023:-adjusted-net-loss-narrowed-down-30.3%-yoy,-strategic-focus-enhanced-business-resilience

Yidu Tech Announces Results for the First Half of FY2023: Adjusted Net Loss Narrowed down 30.3% YoY, Strategic Focus Enhanced Business Resilience

 

Yidu Tech Inc. (“Yidu Tech” or “the Company”, together with its subsidiaries and consolidated affiliated entities, “the Group”, HKEx: 2158), a leading corporate in China’s healthcare intelligence industry, announced the interim results for the six months ended 30 September 2022 (“the first half of FY2023” or “the Reporting Period”).

Despite the challenging and uncertain external environment, the Group remained committed to improving profitability with a strategic focus. The Group continues to focus on applying digital and intelligent applications to multiple use-case scenarios, concentrating on key disease research areas such as solid tumors, hematology, ophthalmology and immunology to further strengthen its core competence, improve customer experience and increase customers’ average transaction value. During the Reporting Period, the Group reported a total revenue of RMB474.4 million and adjusted net loss narrowed to RMB224.8 million, a decrease of 30.3% year-on-year. Total operating expense as a percentage of revenue decreased by 32.1 percentage points.

Ms. Gong Yingying (Rujing), Chairlady and Founder, Executive Director and Chief Executive Officer of Yidu Tech, stated, “The Group has taken proactive and effective measures to enhance operational efficiency and has successfully narrowed its loss and adjusted net loss significantly during the Reporting Period, which is a testament to the effectiveness of our business development strategy. We expect a continued improvement in operation efficiency going forward, and we will continue to make progress toward achieving profitability. Yidu Tech will adhere to its original vision of ‘green healthcare’, continue to enhance its core technology capabilities, and deepen its efforts in the three scenario categories of research, diagnosis and treatment, and public health, in order to create more value in the healthcare intelligence industry.”

Deep cultivation of three major scenarios with strategic focus on aiding commercialization

During the Reporting Period, Yidu Tech proactively enhanced its profitability with a strategic focus on four major areas: business, customers, diseases and organization.

In terms of business, Yidu Tech continues to focus on scenarios in three major categories, namely research, diagnosis and treatment, and public health. The Company promotes multi-scenario applications based on the three categories, achieving scenario-driven optimization of intelligence. Driven by innovation, the Group continuously upgrades its portfolio of high-quality professional products and services to meet the diverse demands of its core customers.

In terms of customers, Yidu Tech focuses on serving core hospitals and core pharmaceutical companies with high revenue retention. In the Big Data Platform and Solutions (“BDPS”) segment, the Company upgraded and launched the All Disease Data Platform, which facilitates the DIY creation of disease registries by hospitals. In addition, in the Life Science Solutions (“LSS”) segment, the revenue retention rate for the top 10 clients reached 119%.

In terms of diseases, during the Reporting Period, the Group concentrated on key disease research areas including solid tumors, hematology, ophthalmology and immunology. Regarding organization, based on the intelligent “medical brain” YiduCore and the overlapping applications of its core capabilities, Yidu Tech continued to enhance the synergy among the three business segments and to increase customer awareness. Meanwhile, the Group continuously improved the business penetration and internal operating efficiency, and continued to reduce the ratio of total operating expense to revenue during the Reporting Period, which was brought down by 32.1 percentage points year-on-year.

Continuous Technological Innovation to Drive the Development of the Healthcare Intelligence Ecosystem

Guided by the national strategy of high-quality development driven by innovation, the “14th Five-Year Plan” and the “Healthy China 2030” policy, China has put in place series of policies to encourage scenario-driven proprietary innovation. As a leading corporate in the healthcare intelligence industry, Yidu Tech has continuously improved its capabilities in independent R&D and innovation, focusing on solving the pain points faced by the healthcare industry as it undergoes an intelligent transformation.

Over the years, Yidu Tech has independently developed YiduCore which consists of algorithms and insightful medical knowledge that are continuously accumulated and constantly iterated as the Group expands its use-case scenarios with proper authorization. In the first half of FY2023, Yidu Tech continued to invest resources in cooperation with renowned hospitals and experts, to continue empowering its ability to build and enrich a disease labelling system that encompasses various fields of diseases. As of 30 September 2022, YiduCore’s medical knowledge graph covers over 80,000 medical objects, of which the number of diseases covered by the disease knowledge graph has exceeded 10,000, an increase of over 1,000 compared to six months earlier.

With YiduCore’s strong data processing capabilities and AI algorithms, as well as its accumulated medical knowledge, insights and disease models, Yidu Tech has undertaken a total of 19 scientific research projects with its partners, including renowned hospitals, regulators and universities, of which 8 are national-level research projects sponsored by the Ministry of Science and Technology of China and other national ministries. As of 30 September 2022, the effectiveness and accuracy of its pandemic response and prediction algorithms have been validated in 22 cities.

In terms of privacy protection, the Company participated in the preparation of the Research Report on the Application of Privacy Computing (2022) issued by the Institute of Cloud Computing and Big Data of the China Academy of Information and Communication Technology (CAICT). In addition, by virtue of its outstanding remote operation and maintenance technology, Yidu Tech obtained the Certificate of Remote Operation and Maintenance Safety Capability Inspection issued by the Internet Health Care Industry Alliance and CAICT.

Balanced development of three business segments, demonstrating strong business resilience

During the Reporting Period, the revenue of all three business segments maintained a balanced development, demonstrating strong business resilience.

The Big Data Platform and Solutions segment generated revenues of RMB 124.0 million during the Period. One aspect of this segment is Yidu Tech’s provision of AI-based intelligence platforms and data analytics-driven solutions to regulators and policy makers. During the Reporting Period, the Group led a consortium and won the contract for the Infectious Disease Intelligent Multi-point Surveillance Early Warning Platform for Beijing. With AI-empowered analytical tools and top-notch simulation models, the Group has expanded its solution offerings from public health to population health. During the Reporting Period, the Group won the construction of regional healthcare profiling for local residents in Chaoyang District, Beijing.

The other aspect of this segment is the Group’s continued effort to deepen its insight into diseases. In the field of hematology, the Group has partnered with two of China’s only three hematologic diseases National Clinical Research Center (NCRC) hospitals in developing a hematologic disease research network to conduct efficient clinical trials and multi-institutional real-world studies. Meanwhile, the Group has assisted its clients to develop a number of disease registries and large clinical research cohorts for major hematological diseases, including leukemia, coagulation disorders and aplastic anemia. With the successful precedented cases in hematology, the Group made breakthroughs in the field of dermatology by winning the contract with Institute of Dermatology, Chinese Academy of Medical Sciences, one of China’s top two hospitals in the field of dermatology, to build a disease research platform.

The Life Science Solutions segment achieved revenue of RMB 146.5 million during the Reporting Period. With accumulated credentials in focused disease research areas, as of 30 September 2022, Yidu Tech has performed 232 clinical research trials, including clinical trials sponsored by pharmaceutical companies and investigator-initiated trials (IIT). The Group has performed 185 prospective and retrospective real-world studies. Its Intelligent Site Management Organization (iSMO) services have covered 163 sites, more than doubling the number from last year. It is worth noting that, during the Reporting Period, the Group conducted a comprehensive retrospective real-world study which related to the evaluation of the efficacy, safety and treatment modalities of a new drug for patients with complex abdominal infections in ICU for a top 20 multi-national pharmaceutical companies (MNC) client to assist it to obtain the approval from the Center for Drug Evaluation, National Medical Products Administration (CDE).

The growing track records has enabled the Group to continuously develop the LSS segment and maintain its high-quality customer base. As of 30 September 2022, there were 143 active clients. Among its top 20 clients, there were 7 MNC and 16 listed companies.

The revenue of the Group’s Health Management Platform and Solutions segment amounted to RMB 203.8 million. Leveraging medical insights powered by YiduCore and AI empowerment, Yidu Tech facilitated its customers’ ability to design and develop innovative insurance products, enabling faster and more accurate insurance underwriting and expediting claim processing. During the Reporting Period, the Group continued to increase the market penetration of the Hui Min Bao business, serving 3 provinces and 10 cities. Yidu Tech has assisted three of the four municipalities directly under the central government in China to launch Hui Min Bao products, including TianjinBeijing and Chongqing. As of 30 September 2022, the number of active users who have completed at least one transaction on Yidu Tech’s health management platform reached 15 million.

Furthermore, the Group’s advanced intelligence technologies greatly improve the operating efficiency of Hui Min Bao. As the main operating platform for Jiangsu Hui Min Bao, the Group underwrote more than 3 million Jiangsu Hui Min Bao policies and approximately 76% of total claim amounts were completed by the Group’s intelligent claim settlement services. Compared with traditional methods, the Group’s intelligent claim settlement services tripled the productivity of processing claims, reducing the financial burden of the insured and further encouraging participation.

As the market leader with the largest market share in the healthcare intelligence market, the medical institutions and regulatory agencies healthcare intelligence market as well as the emerging healthcare intelligence market in China, Yidu Tech is committed to contributing to the intelligent transformation and upgrading of the healthcare industry, as well as the high-quality development of the healthcare industry. In the future, Yidu Tech will continue to adhere to its two-pronged strategy, expand its infrastructure network, deepen its research into diseases, maintain its strategic focus on business, customers, diseases and organization, and contribute to creating the healthcare intelligence ecosystem, upholding its mission to make value-based precision healthcare accessible to everyone and create more value for healthcare industry participants.

[24]7.ai-positioned-as-the-leader-in-the-2022-spark-matrix-for-virtual-customer-assistants-by-quadrant-knowledge-solutions

[24]7.ai positioned as the Leader in the 2022 SPARK Matrix for Virtual Customer Assistants by Quadrant Knowledge Solutions

 

Quadrant Knowledge Solutions announced today that it has named [24]7.ai, Inc. as a 2022 technology leader in the SPARK Matrix analysis of the global Virtual Customer Assistants market.

The Quadrant Knowledge Solutions SPARK Matrix™ includes a detailed analysis of global market dynamics, major trends, vendor landscape, and competitive positioning. The study provides competitive analysis and ranking of the leading technology vendors in the form of its SPARK Matrix. It gives strategic information for users to evaluate different provider capabilities, competitive differentiation, and market position.

According to Kunal Pakhale, Analyst, Quadrant Knowledge Solutions, “[24]7.ai’s Virtual Customer Assistants capabilities include its continuous learning from intent discovery to tuning, superior intent prediction, and open AI infrastructure, enabling users to coordinate, monitor, and explain multiple models. It also offers low-code AI development tools and assistive AI for non-technical users to build models and design conversations. Additionally, [24]7.ai offers a single platform for digital and voice with state-of-the-art natural language understanding and context awareness. [24]7.ai is capable of catering to diverse customer needs across industry verticals; with its comprehensive capabilities, compelling customer references, comprehensive roadmap and vision, cloud-native platform, and product suite with high scalability, have received strong ratings across technology excellence and customer impact and has been positioned as a leader in SPARK Matrix: Virtual Customer Assistants, 2022.”

“[24]7.ai’s key strength is its platform [24]7 Lumos AI, which enables a constellation of AI driven tools to build enterprise grade chatbots and keep them running for years. Starting at discovering topics of user conversations – digital or voice, our platform provides tools to author bot conversation flows and augment them with rich AI models that can accurately identify sentiments and intents using advanced NLP algorithms.”

“Most seasoned practitioners know that deploying a bot once is never enough – since conversation topics and user behavior inevitably change over time. Our tools make it easy to manage this part of the bot lifecycle too: we provide a dashboard for automatic model monitoring that signals changes in bot or model performance, letting practitioners know when to revisit a model or flow design. Our explainable AI feature – soon to be out of labs – further eases this process by providing a transparent view of a model’s reasoning,” said Michelle Gregory, SVP, Data Science at [24]7.ai

Michelle continued, “In short, [24]7 Lumos AI codifies 20+ years of our experience in running customer service solutions, providing a 360 degree view and control over all workflows needed to run a successful and robust conversational AI system.”

Quadrant Knowledge Solutions defines a Virtual Customer Assistants as a programming application that replicates human-like conversations to deliver information to customers, including text-based and speech-based engagements. The VCA adapts to the content and context of user inputs by combining natural-language processing and conversational artificial intelligence by updating its data repositories in real-time, providing sustained and strong customer value proposition, and enabling organizations to have an open channel to serve and communicate with their customers.

VCA vendors are focusing on strengthening their platform capabilities by leveraging AI/ML and analytics to gain and understand buyer insights. Vendors continue to augment their AI models to understand customer behavior, actions, intent, context, and sentiment. Furthermore, organizations are constantly looking for virtual assistants that can offer a personalized CX, adapt to their evolving business models, and enable them to efficiently design business and customer-centric strategies. AI is furthering the benefits of VCAs, which are being developed by technology corporations to boost revenue and employment and improve corporate operations.

Additional Resources:

xinhua-silk-road:-shanghai-international-shipping-center-enters-new-stage-of-comprehensive-development

Xinhua Silk Road: Shanghai International Shipping Center enters new stage of comprehensive development

 

Shanghai International Shipping Center has entered a new stage of comprehensive development featuring green transformation, digital intelligence and strong resilience, according to participants of the 2022 North Bund Forum.

Held in Shanghai from November 22 to 24, the forum attracted representatives from leading shipping and aviation enterprises and international organizations, as well as well-known experts, to discuss the sustainable development for the international shipping industry.

Shanghai Port, ranking first worldwide in container throughput for 12 consecutive years, is staging green transformation and becoming an increasingly clean, energy-saving and efficient modern hub port.

Statistics showed that in Shanghai Port, the water-to-water transhipment ratio of containers has reached more than 50 percent, the ship-to-ship synchronous LNG bunkering service has achieved normal operation, and about 97.95 percent of the operating ships have been renovated with shore power receiving facilities.

Zhang Wei, vice mayor of Shanghai, said that Shanghai has made every effort to play its role as a pioneer and a demonstration leader in promoting the development of green shipping.

Meanwhile, digitalization is reshaping the production mode, business model, organizational form and operation order of Shanghai International Shipping Center, and expanding the radiation scope of the center.

On September 3 this year, an empty container transfer center in Shanghai Port was newly launched, which allows empty containers to be transported to the Yangtze River Delta region and ports along the Yangtze River through water, highway and railway, further enhancing the resource allocation capacity of Shanghai Port as an international shipping hub.

Yu Fulin, director of Shanghai Municipal Transportation Commission, said that in order to improve the resilience of the supply chain and industrial chain, Shanghai has worked with the Yangtze River Delta to accelerate the construction of a global shipping hub, improve the smooth and resilient shipping collection and distribution system, as well as comprehensively promote the shipping service and brand influence.

In the first three quarters of this year, the container throughput of Shanghai Port reached 34.89 million TEUs, achieving positive growth year on year and showing strong growth resilience.

turku-energia-sahkoverkot-and-landis+gyr-extend-smart-metering-and-managed-services-cooperation

Turku Energia Sähköverkot and Landis+Gyr Extend Smart Metering and Managed Services Cooperation

 

Turku Energia Sähköverkot Oy decided to continue its long-term metering service cooperation with Landis+Gyr Oy (SIX: LAND). The metering agreement covers the delivery of a total of 125,000 smart meters, reliable IoT communication and a 10-year managed service agreement. Landis+Gyr will install 95,000 smart meters and Turku Energia Sähköverkot Oy 30,000.

Turku Energia Sähköverkot’s entire existing metering equipment will be replaced with new, efficient and intelligent measurement devices (E360, E360 CT, E660) in the coming years. The new smart meters and services will meet all the requirements of the new metering regulation, including a 15-minute or shorter measurement period, extensive power quality monitoring capabilities and interfaces with home automation. In addition, reliable and cost-effective mobile IoT technologies (NB-IoT and LTE M1) will replace the existing telecommunications solution.

“We are very pleased with our long-standing partnership with Landis+Gyr and are delighted to continue it with this measurement service partnership,” said Tomi Toivonen, Managing Director of Turku Energia Sähköverkot Oy. “Our new agreement will secure energy metering for our customers well into the future. Energy metering plays a very important role in meeting Finland’s energy supply and environmental objectives, both today and tomorrow. We believe that our cooperation will support our customers in managing these also in the future.”

As a pioneer in the introduction of smart metering on a large scale, Finland’s new regulation requires installed devices to not only act as electricity meters but also as smart sensors capable of managing advanced power quality measurements and automated controls at the edge of the grid.

“In light of the current energy crisis, the need for intelligence at the grid edge has never been more crucial,” said Tommi Österberg, Sales Director at Landis+Gyr. “Energy companies require fast, reliable and secure data transmission and our ability to monitor and process data will contribute to better load balancing, power quality and reliability. We look forward to supporting this effort and managing energy better together.”

Turku Energy Electricity Networks
Turku Energia Sähköverkot Oy is responsible for the distribution of electricity in almost the entire area of the city of Turku, with the aim of providing a reliable, high-quality and affordable supply of electricity. We are constantly developing our electricity network to meet our customers’ needs. At the end of 2021, Turku Energia Sähköverkot had a total of approximately 96,000 electricity metering points of use and we transferred approximately 1,573 GWh of electricity to customers in our own network area. Our pricing is among the lowest in the country in a national comparison. Turku Energia Sähköverkot Oy is a subsidiary of Turku Energia. https://www.turkuenergia.fi/sahkoverkot/tietoa-sahkoverkostamme/turku-energia-sahkoverkot-oy/

Landis+Gyr
Landis+Gyr is a leading global provider of integrated energy management solutions. We measure and analyze energy utilization to generate empowering analytics for smart grid and infrastructure management, enabling utilities and consumers to reduce energy consumption. Our innovative and proven portfolio of software, services and intelligent sensor technology is a key driver to decarbonize the grid. Having avoided more than 9 million tons of CO2 in FY 2021, Landis+Gyr manages energy better – since 1896. With sales of USD 1.5 billion in FY 2021, Landis+Gyr employs around 6,800 talented people across five continents. For more information, please visit our website www.landisgyr.eu.

akirolabs-named-2022-gartner-cool-vendor

akirolabs named 2022 Gartner® Cool Vendor™

 

akirolabs, a Berlin-based technology start-up offering a digital, collaborative strategic procurement solution, announced today that it was named a 2022 Gartner® Cool Vendor™ in this year’s “Cool Vendors™ in Sourcing and Procurement Technology” report. The recognition underlines the startup’s ambition to provide a holistic strategy platform for procurement organizations.

Detlef Schultz, Co-Founder of akirolabs: “We are extremely proud and humbled to be named 2022 Cool Vendor™ by Gartner®. This recognition emphasizes the importance of cross-functional collaboration in procurement, not only in times of black swan events, crisis and war. We will continue to shape the future of procurement together with our global advisory board from various industries such as Media, Banking, Pharma, Telco and Consumer Goods as well as scientific and tech experts. In doing so, we will elevate procurement beyond traditional category management towards a truly strategic business function.”

According to Gartner’s® 2022 Cool Vendor™ report, procurement serves a critical role in today’s challenging economic times and uncertain business environments, while often being resource-constrained and relying heavily on internal knowledge silos.

Koray Köse, Senior Director at Gartner®: “akirolabs complements traditional S2C and P2P capabilities providing a holistic sourcing strategy platform. It enables digitized sourcing strategy creation in collaboration with stakeholders and enriches the process with relevant market insights through its AI enabled user cockpit. […] This can help drive early engagement and innovation collaboration with stakeholders inclusively and manage value streams beyond a limited category niche.” He further states that it “enables clients to measure and prioritize decisions that move traditional supply management towards ecosystem management with “higher purpose”. Incorporating value-based sourcing that considers sustainability aspects as well as profitability and compliance is a differentiator this solution provides.”

The Gartner® report highlights that deploying innovative technology to support business processes powered by artificial intelligence (AI) and advanced analytics is an important digital initiative for procurement organizations to keep at the top of their agendas.

“cool-japan-data-&-digital-marketing-festival”-held-from-21st-to-24th-of-november

“Cool Japan Data & Digital Marketing Festival” held from 21st to 24th of November

 

The Cool Japan Data & Digital Marketing Festival Executive Committee [Secretariat: Vpon Japan K.K., located in Shinjuku, Tokyo, with the Executive Director Yoshitaka Shinohara (Chief Strategy Officer at Vpon Japan K.K.)] convened the “First Cool Japan Data & Digital Marketing Festival 2022“, an online and offline event intended to enhance the digital shifting opportunity of the Cool Japan Strategy, promoted by the Japanese Government from November 21 (Monday) to 24 (Thursday), 2022.

The opening session conducted on November 21, the first day of the event, demonstrated the importance of utilizing data and conducting digital marketing, with the participation of key persons representing both public and private sectors, such as Mr. Hidetoshi Nakata, the Representative Director of Japan Craft Sake Company Co., Ltd., as well as representatives of Japan National Tourism Organization, Osaka Convention and Tourism Bureau, Agency for Cultural Affairs of Japan, Otafuku Sauce Co., Ltd., Japan Professional Football League, Ebara Foods Industry, Inc., among others, taking the platform. Mr. Yoshitaka Shinohara, the CSO of Vpon Holdings and the organizer of this evet pointed out “the main issue for the the Cool Japan Strategy is defenitely the needs the data & digital marketing”. Mr. Kyoji Kuramochi, Deputy Director for JNTO added  “We need to use the data as much as possible and analyse them”. Mr. Hiroya Miyata, Otafuku Sauce company which covers over 50 countries stated “We have used the digital marketing to promote our products in the countries which nobody knows our products”, and showed the potentials for global market implementations by utilizing big data and digital technologies.

Furthermore, the “1st Cool Japan Data & Digital Marketing Award” that awarded prizes to examples of advanced digital marketing associated with Cool Japan, was also convened at the same time, and on this occasion, Niigata Prefecture & Zeroin, was awarded the Grand Prize for Excellence. The judges commented “every finalists show their love for Japan and the local area, which was excellent.”

This very first event was attended by such individuals as business operators seeking to accelerate overseas implementation of their products and services while Japanese yen is depreciated, as well as tourism industry-related people who are seeking to disseminate information about regional attractions to the world. The event offered a significant impact for people seeking to accelerate implementation of their product and service offerings to tourists visiting Japan, while the inbound demand is in a trend of recovery. The Executive Committee intends to continue providing support to enhance digital shifting opportunities in the future. (Watch Replay)